SB4-G31-RA:Phase 3 SB4 Compared to Enbrel in Rheumatoid Arthritis

• Research type

  Research Study

• Full title

  A Randomised, Double-blind, Parallel Group, Multicentre Clinical Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity of SB4 Compared to Enbrel® in Subjects with Moderate to Severe Rheumatoid Arthritis despite Methotrexate Therapy

• IRAS ID

  124402

• Contact name

  Jennifer Peach

• Contact email

  Jennifer.peach@uhs.nhs.uk

• Sponsor organisation

  Samsung Bioepis Co., Ltd.

• Eudract number

  2012-005026-30

• ISRCTN Number

  xx

• REC name

  London - Chelsea Research Ethics Committee

• REC reference

  13/LO/0356

• Date of REC Opinion

  3 May 2013

• REC opinion

  Further Information Favourable Opinion